Cinacalcet upregulates calcium-sensing receptors of parathyroid glands in hemodialysis patients

American Journal of Nephrology

Volumn 37, Issue 5, 2013, Pages 405-412

  Sumida, Keiichi ^a   Nakamura, Michio ^b   Ubara, Yoshifumi ^a   Marui, Yuji ^a   Tanaka, Kiho ^a   Takaichi, Kenmei ^a   Tomikawa, Shinji ^a   Inoshita, Naoko ^a   Ohashi, Kenichi ^a  

^a TORANOMON HOSPITAL   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Calcium sensing receptor; Cinacalcet hydrochloride; Parathyroid gland; Secondary hyperparathyroidism

Indexed keywords

ANTIBODY; CALCITRIOL; CALCIUM SENSING RECEPTOR; CINACALCET; STEROL; VITAMIN D; 22 OXACALCITRIOL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; NODULAR HYPERPLASIA; PARATHYROID GLAND; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SECONDARY HYPERPARATHYROIDISM; THYROID HYPERPLASIA; TREATMENT DURATION; UPREGULATION; CHRONIC KIDNEY FAILURE; HISTOPATHOLOGY; HUMAN TISSUE; PARATHYROID HYPERPLASIA;

FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NAPHTHALENES; PARATHYROID GLANDS; RECEPTORS, CALCIUM-SENSING; RENAL DIALYSIS; UP-REGULATION;

EID: 84876077562     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000350211     Document Type: Article

References (24)

1. Drueke TB: Cell biology of parathyroid gland hyperplasia in chronic renal failure. J Am Soc Nephrol 2000; 11: 1141-1152
2. Goodman WG, Quarles LD: Development and progression of secondary hyperparathyroidism in chronic kidney disease: Lessons from molecular genetics. Kidney Int 2008; 74: 276-288
3. Brown EM, Gamba G, Riccardi D, Lombardi M, Butters R, Kifor O, Sun A, Hediger MA, Lytton J, Hebert SC: Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature 1993; 366: 575-580
4. Canadillas S, Canalejo A, Santamaria R, Rodriguez ME, Estepa JC, Martin-Malo A, Bravo J, Ramos B, Aguilera-Tejero E, Rodriguez M, Almaden Y: Calcium-sensing receptor expression and parathyroid hormone secretion in hyperplastic parathyroid glands from humans. J Am Soc Nephrol 2005; 16: 2190-2197
5. Fukuda N, Tanaka H, Tominaga Y, Fukagawa M, Kurokawa K, Seino Y: Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 1993; 92: 1436-1443
6. Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, Hercz G, Cunningham J, Abu-Alfa AK, Messa P, Coyne DW, Locatelli F, Cohen RM, Evenepoel P, Moe SM, Fournier A, Braun J, McCary LC, Zani VJ, Olson KA, Drueke TB, Goodman WG: Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 2004; 350: 1516-1525
7. Lindberg JS, Culleton B, Wong G, Borah MF, Clark RV, Shapiro WB, Roger SD, Husserl FE, Klassen PS, Guo MD, Albizem MB, Coburn JW: Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: A randomized, double-blind, multicenter study. J Am Soc Nephrol 2005; 16: 800-807
8. Mizobuchi M, Hatamura I, Ogata H, Saji F, Uda S, Shiizaki K, Sakaguchi T, Negi S, Kinugasa E, Koshikawa S, Akizawa T: Calcimimetic compound upregulates decreased calciumsensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency. J Am Soc Nephrol 2004; 15: 2579-2587
9. Mendoza FJ, Lopez I, Canalejo R, Almaden Y, Martin D, Aguilera-Tejero E, Rodriguez M: Direct upregulation of parathyroid calciumsensing receptor and vitamin D receptor by calcimimetics in uremic rats. Am J Physiol Renal Physiol 2009; 296:F605-F613
10. Guideline Working Group, Japanese Society for Dialysis Therapy: Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients. Ther Apher Dial 2008; 12: 514-525
11. Basile C, Lomonte C, Vernaglione L, Casucci F, Chimienti D, Bruno A, Cocola S, Verrelli EA, Cazzato F: A high body mass index and female gender are associated with an increased risk of nodular hyperplasia of parathyroid glands in chronic uraemia. Nephrol Dial Transplant 2006; 21: 968-974
12. Yano S, Sugimoto T, Tsukamoto T, Chihara K, Kobayashi A, Kitazawa S, Maeda S, Kitazawa R: Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism. Kidney Int 2000; 58: 1980-1986
13. Ritter CS, Martin DR, Lu Y, Slatopolsky E, Brown AJ: Reversal of secondary hyperparathyroidism by phosphate restriction restores parathyroid calcium-sensing receptor expression and function. J Bone Miner Res 2002; 17: 2206-2213
14. Brown AJ, Zhong M, Finch J, Ritter CS, Mc- Cracken R, Morrissey J, Slatopolsky E: Rat calcium-sensing receptor is regulated by vitamin D but not by calcium. Am J Physiol 1996; 270:F454-F460
15. Christie AC: The parathyroid oxyphil cells. J Clin Pathol 1967; 20: 591-602
16. Ritter CS, Haughey BH, Miller B, Brown AJ: Differential gene expression by oxyphil and chief cells of human parathyroid glands. J Clin Endocrinol Metab 2012; 97:E1499-E1505
17. Ritter CS, Haughey BH, Armbrecht HJ, Brown AJ: Distribution and regulation of the 25-hydroxyvitamin D3 1alpha-hydroxylase in human parathyroid glands. J Steroid Biochem Mol Biol 2012; 130: 73-80
18. Lomonte C, Martino R, Selvaggiolo M, Bona RM, Cazzato F, Milano R, Chiarulli G, Basile C: Calcitriol pulse therapy and histology of parathyroid glands in hemodialysis patients. J Nephrol 2003; 16: 716-720
19. Lomonte C, Vernaglione L, Chimienti D, Bruno A, Cocola S, Teutonico A, Cazzato F, Basile C: Does vitamin D receptor and calcium receptor activation therapy play a role in the histopathologic alterations of parathyroid glands in refractory uremic hyperparathyroidism? Clin J Am Soc Nephrol 2008; 3: 794-799
20. Sumida K, Nakamura M, Ubara Y, Marui Y, Tanaka K, Takaichi K, Tomikawa S, Inoshita N, Ohashi K: Histopathological alterations of the parathyroid glands in haemodialysis patients with secondary hyperparathyroidism refractory to cinacalcet hydrochloride. J Clin Pathol 2011; 64: 756-760
21. Rodriguez M, Canalejo A, Garfia B, Aguilera E, Almaden Y: Pathogenesis of refractory secondary hyperparathyroidism. Kidney Int Suppl 2002; 61:S155-S160
22. Drueke T, Martin D, Rodriguez M: Can calcimimetics inhibit parathyroid hyperplasia? Evidence from preclinical studies. Nephrol Dial Transplant 2007; 22: 1828-1839
23. Tominaga Y, Matsuoka S, Uno N, Sato T: Parathyroidectomy for secondary hyperparathyroidism in the era of calcimimetics. Ther Apher Dial 2008; 12(suppl 1):S21-S26
24. Yamamoto M, Ogata H, Mizobuchi M, Yoshida N, Kumata-Maeta C, Koiwa F, Shishido K, Kinugasa E: Number of enlarged parathyroid glands might be a predictor of cinacalcet response in advanced secondary hyperparathyroidism. Clin Exp Nephrol 2012; 16: 292- 299